Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows.

Global: Five largest Private Equity/Venture Financing deals by value in the Pharmaceuticals sector (LTM June 2022)

  • A total of 1,537 Private Equity/Venture Financing deals (pending and completed) were announced in the Global Pharmaceuticals sector, in the last twelve months resulting in a total deal value of over $80,424.3 million. In the LTM period, July 2021 turned out to be the most prolific in terms of deal size, with a total deal value of $14,721.6 million, resulting in an average deal value of $126.9 million during that month. On the other hand, the month of December 2021 was the most prolific in terms of deal volume, recording a total of 149 deals, resulting in an average deal value of $34.5 million during that month.

  • Of the 3,074 deals, the deal secured between EQT AB; EQT Partners AB; Goldman Sachs Asset Management LP and Parexel International Corp, was the largest Private Equity/Venture Financing deal in the Global Pharmaceuticals sector, which was valued at $8,500.0 million and was completed on July 2, 2021. The second-largest deal was between Advent International Corp; Agnafit Bidco AB; Aurora Investment Pte Ltd; GIC Pte Ltd and Swedish Orphan Biovitrum AB, while the third-largest deal was between Partners Group AG and Pharmathen S.A.. The Advent International Corp; Agnafit Bidco AB; Aurora Investment Pte Ltd; GIC Pte Ltd-Swedish Orphan Biovitrum AB deal and the Partners Group AG-Pharmathen S.A. deal were valued at $8,047.6 million and $1,888.7 million, respectively. The fourth-largest deal was between CBC Group-Hugel Inc valued at $1,500.0 million, whereas the deal between Patient Square Capital LP-Summit Behavioral Healthcare LLC valued at $1,300.0 million was the fifth-largest deal.

  • Cumulatively, the top five deals amounted to $21,236.4 million and accounted for nearly 26.41% of the total deals (by value) announced during the last twelve months. By region, North America accounted for 55.40% of the total Private Equity/Venture Financing deals done globally, and recorded a total deal value of $44,544.9 million, which accounted for 59.41% of the total deal size on a global scale.

Global: Five largest Private Equity/Venture Financing deals by value in the Pharmaceuticals sector (LTM June 2022)

Published: June 2022
Source: GlobalData

Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Explore the latest deal across all financial deal types and actionable insights by Theme and Sector to support your business activities and workflows. Visit Report Store
Still looking?

Don’t wait - discover a universe of connected data & insights with your next search. Browse over 28M data points across 22 industries.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward